The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Vasiliev V.I.

Laboratory of Intensive Therapeutic Techniques, Federal state budgetary institution 'V.A. Nasonova Research Institute of Rheumatology', Russian Academy of Medical Sciences

Sokol E.V.

FGBU "NII revmatologii im. V.A. Nasonovoĭ" RAMN, Moskva

Kokosadze N.V.

Rossiĭskiĭ onkologicheskiĭ nauchnyĭ tsentr im. N.N. Blokhina RAMN, Moskva

Pavlovskaya A.I.

N.N. Blokhin Russian Cancer Research Center, Moscow, Russia

Komov D.V.

Rossiĭskiĭ onkologicheskiĭ nauchnyĭ tsentr im. N.N. Blokhina RAMN, Moskva

Pal’shina S.G.

Laboratory of Intensive Therapy of Rheumatic Diseases, Federal state budgetary scientific institution «V.A. Nasonova Research Institute of Rheumatology», Moscow, Russia

Mukhortova O.V.

FGBU "NII serdechno-sosudistoĭ khirurgii im. N.N. Bakuleva" RAMN, Moskva

Safonova T.N.

FGBU "NII glaznykh bolezneĭ" RAMN, Moskva

The differential diagnosis of Erdheim-Chester disease and IgG4-related diseases

Authors:

Vasiliev V.I., Sokol E.V., Kokosadze N.V., Pavlovskaya A.I., Komov D.V., Pal’shina S.G., Mukhortova O.V., Safonova T.N.

More about the authors

Journal: Therapeutic Archive. 2016;88(5): 70‑76

DOI: 10.17116/terarkh201688570-76

Read: 8810 times

Download PDF (RU)
Contact the author
Table of contents

THE DIFFERENTIAL DIAGNOSIS OF ERDHEIM-CHESTER DISEASE AND IGG4-RELATED DISEASES
THE DIFFERENTIAL DIAGNOSIS OF ERDHEIM-CHESTER DISEASE AND IGG4-RELATED DISEASES

To cite this article:

Vasiliev VI, Sokol EV, Kokosadze NV, et al. . The differential diagnosis of Erdheim-Chester disease and IgG4-related diseases. Therapeutic Archive. 2016;88(5):70‑76. (In Russ.)
https://doi.org/10.17116/terarkh201688570-76

МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Eosi­nophilic cells asso­ciated with BRAF muta­tion in borderline serous ovarian tumors. Russian Journal of Archive of Pathology. 2025;(2):18-23
Abstract:

The paper describes Russia’s first diagnosed case of Erdheim—Chester disease (systemic histiocytosis) in a 65-year-old man who has been long treated for Ormond’s disease (idiopathic retroperitoneal fibrosis). It also gives the data available in the literature on the pathogenetic components of these diseases and on the similarity of many clinical, laboratory, and morphological characteristics of these two immunoinflammatory diseases and covers the issues of their differential diagnosis. Invasive procedures with a careful morphological/immunomorphological examination of biopsy specimens obtained from affected tissues are shown to be necessary for accurate diagnosis.

Keywords:

Erdheim—Chester disease
idiopathic retroperitoneal fibrosis
IgG4-related diseases
non-Langerhans cell histiocytosis
Ormond’s disease
BRAFV600E mutation

Authors:

Vasiliev V.I.

Laboratory of Intensive Therapeutic Techniques, Federal state budgetary institution 'V.A. Nasonova Research Institute of Rheumatology', Russian Academy of Medical Sciences

Sokol E.V.

FGBU "NII revmatologii im. V.A. Nasonovoĭ" RAMN, Moskva

Kokosadze N.V.

Rossiĭskiĭ onkologicheskiĭ nauchnyĭ tsentr im. N.N. Blokhina RAMN, Moskva

Pavlovskaya A.I.

N.N. Blokhin Russian Cancer Research Center, Moscow, Russia

Komov D.V.

Rossiĭskiĭ onkologicheskiĭ nauchnyĭ tsentr im. N.N. Blokhina RAMN, Moskva

Pal’shina S.G.

Laboratory of Intensive Therapy of Rheumatic Diseases, Federal state budgetary scientific institution «V.A. Nasonova Research Institute of Rheumatology», Moscow, Russia

Mukhortova O.V.

FGBU "NII serdechno-sosudistoĭ khirurgii im. N.N. Bakuleva" RAMN, Moskva

Safonova T.N.

FGBU "NII glaznykh bolezneĭ" RAMN, Moskva

Close metadata

References:

  1. Сhester W. Über lipoid Granulomatose. Virchows Archiv für pathologische Anatomie und Physiologie und für klinische Medizin. 1930;279(2):561-602.  doi:10.1007/BF01942684.
  2. Erdheim-Chester Disease Global Alliance Available at: http://erdheim-chester.org/
  3. Mazor R, Manevich-Mazor M, Kesler A, Aizenstein O, Eshed I, Jaffe R, Pessach Y, Goldberg I, Sprecher E, Yaish I, Gural A, Ganzel C, Shoenfeld Y. Clinical considerations and key issues in the management of patients with Erdheim-Chester Disease: a seven case series. BMC Medicine. 2014;12:221-239.  doi:10.1186/s12916-014-0221-3.
  4. Campochiaro C, Tomelleri A, Cavalli G, Berti A, Dagna L. Erdheim-Chester disease. Eur J Int Med. 2015;26:223-229.  doi:10.1016/j.ejim.2015.03.004.
  5. Munoz J, Janku F, Cohen PR, Kuiziock R. Erdheim-Chester disease: characteristics and management. Mayo Clinic Proceedings. 2014;89:985-996.  doi:10.1016/j.mayocp.2014.01.023.
  6. Diamond EL, Dagna L, Hyman DM, Cavalli G, Janku F, Estrada-Veras J, Ferrarini M, Abdel-Wahab O, Heaney ML, Scheel PJ, Feeley NK, Ferrero E, McClain KL, Vaglio A, Colby T, Arnaud L, Haroche J. Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease. Blood. 2014;124:483-492.  doi:10.1182/blood-2014-03-561381.
  7. Chetritt J,Paradis V,Dargere D, Adle-Biassette H, Maurage C, Mussini J, Vital A, Wechsler J, Bedossa P. Chester-Erdheim disease: a neoplastic disorder. Human Pathol. 1999;30(9):1093-1096. doi:10.1016/S0046-8177(99)90228-9.
  8. Gong L, He XL, Li Y, Ren K, Zhang L, Liu X, Han X, Yao L, Zhu S, Lan M, Zhang W. Clonal status and clinicopathological feature of Erdheim-Chester disease. Pathology - Research and Practice. 2009;205(9):601-607.  doi:10.1016/j.prp.2009.02.004.
  9. Stoppacciaro A, Ferrarini M, Salmaggi C, Colarossi C, Praderio L, Tresoldi M, Beretta A, Sabbadini M. Immunochistochemical evidence of a cytokine and chemokine network in three patients with Erdheim-Chester disease: implications for pathogenesis. Arthritis Rheum. 2006;54(12):4018-4022. doi:10.1002/art.22280.
  10. Zhang W. BRAF inhibitors: the current and the future. Curr Opin Pharmacol. 2015;23:68-73.  doi:10.1016/j.coph.2015.05.015.
  11. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR, Futreal PA. Mutations of the BRAF gene in human cancer. Nature. 2002;417:949-954.  doi:10.1038/nature00766.
  12. Badalian-Very G, Vergilio J, Degar BA, MacConaill L, Brandner B, Calicchio M, Kuo F, Ligon A, Stevenson K, Kehoe S, Garraway L, Hahn W, Meyerson M, Fleming M, Rollins B. Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood. 2010;116(11):1919-1923. doi:10.1182/blood-2010-04-279083.
  13. Haroche J, Charlotte F, Arnaud L, von Deimling A, Hélias-Rodzewicz Z, Hervier B, Cohen-Aubart F, Launay D, Lesot A, Mokhtari K, Canioni D, Galmiche L, Rose C, Schmalzing M, Croockewit S, Kambouchner M, Copin MC, Fraitag S, Sahm F, Brousse N, Amoura Z, Donadieu J, Emile JF. High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses. Blood. 2012:120(13):2700-2703. doi:10.1182/blood-2012-05-430140.
  14. Cangi MG, Biavasco R, Cavalli G, Grassini G, Dal-Cin E, Campochiaro C, Guglielmi B, Berti A, Lampasona V, von Deimling A, Sabbadini MG, Ferrarini M, Doglioni C, Dagna L. BRAFV600E-mutation is invariably present and associated to oncogene-induced senescence in Erdheim-Chester disease. Ann Rheum Dis. 2015;74(8):1596-1602. doi:10.1136/annrheumdis-2013-204924
  15. Diamond EL, Abdel-Wahab O, Pentsova E, Borsu L, Chiu A, Teruya-Feldstein J, Hyman DM, Rosenblum M. Detection of an NRAS mutation in Erdheim-Chester disease. Blood. 2013;122(6):1089-1091. doi:10.1182/blood-2013-02-482984.
  16. Haroche J, Cohen-Aubart F, Emile JF, Maksud P, Drier A, Tolédano D, Barete S, Charlotte F, Cluzel P, Donadieu J, Benameur N, Grenier PA, Besnard S, Ory JP, Lifermann F, Idbaih A, Granel B, Graffin B, Hervier B, Arnaud L, Amoura Z. Reproducible and Sustained Efficacy of Targeted Therapy With Vemurafenib in Patients With BRAFV600E -Mutated Erdheim-Chester Disease. J Clin Oncol. 2015;33(5):411-418.  doi:10.1200/JCO.2014.57.1950.
  17. Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, Matsui S, Sumida T, Mimori T, Tanaka Y, Tsubota K, Yoshino T, Kawa S, Suzuki R, Takegami T, Tomosugi N, Kurose N, Ishigaki Y, Azumi A, Kojima M, Nakamura S, Inoue D. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Modern Rheumatol. 2012;22:1-14.  doi:10.1007/s10165-011-0508-6.
  18. Deshpande V. The pathology of IgG4-related disease: critical issues and challenges. Semin Diagn Pathol. 2012;29:191-196.  doi:10.1053/j.semdp.2012.08.001.
  19. Zen Y, Nakamura Y. IgG4-related disease: a cross-sectional study of 114 cases. Am J Surg Pathol. 2010;34:1812-1819. doi:10.1097/PAS.0b013e3181f7266b.
  20. Mahajan VS, Mattoo H, Deshpande V, Pillai SS, Stone JH. IgG4-Related Disease. Ann Rev Pathol. 2014;9:315-347.  doi:10.1146/annurev-pathol-012513-104708.
  21. Stone JH, Patel VI, Olivera GR, Stone JR. Case records of the Massachutts General Hospital. Case 38-2012. A 60-year-old man with abdominal pain and aortic aneurysms. New Engl J Med. 2012;367(24):2335-2346. doi:10.1056/NEJMcpc1209330.
  22. Stone JH. Mechanisms of disease.IgG4-Related disease. New Engl J Med. 2012;366:539-551.  doi:10.1056/NEJMra1104650.
  23. Kamisawa T, Anjiki H, Egawa N, Kubota N. Allergic manifestations in autoimmune pancreatitis. Eur J Gastroenterol Hepatol. 2009;21:1136-1139. doi:10.1097/MEG.0b013e3283297417.
  24. Zen Y, Fujii T,Harada K, Kawano M, Yamada K, Takahira M, Nakanuma Y. Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology. 2007;45:1538-1546. doi:10.1002/hep.21697.
  25. Kanari H, Kagami S, Kashiwakuma D, Oya Y, Furuta S, Ikeda K, Suto A, Suzuki K, Hirose K, Watanabe N, Okamoto Y, Yamamoto S, Iwamoto I, Nakajima H. Role of Th2 cells in IgG4-related lacrimal gland enlargement. Int Arch Allergy Immunol. 2010;152(suppl 1):47-53.  doi:10.1159/000312125.
  26. Detlefsen S, Sipos B, Zhao J, Drewes AM, Klöppel G. Autoimmune pancreatitis: expression and cellular source of profibrotic cytokines and their receptors. Am J Surg Pathol. 2008;32:986-995.  doi:10.1097/PAS.0b013e31815d2583.
  27. Miyoshi H, Uchida K, Taniguchi T, Yazumi S, Matsushita M, Takaoka M, Okazaki K. Circulating naïve and CD4+CD25high regulatory T cells in patients with autoimmune pancreatitis. Pancreas. 2008;36:133-140.  doi:10.1097/MPA.0b013e3181577553.
  28. Stone JH, Khosroshahi A, Deshpande V, Chan JK, Heathcote JG, Aalberse R, Azumi A, Bloch DB, Brugge WR, Carruthers MN, Cheuk W, Cornell L, Castillo CF, Ferry JA, Forcione D, Klöppel G, Hamilos DL, Kamisawa T, Kasashima S, Kawa S, Kawano M, Masaki Y, Notohara K, Okazaki K, Ryu JK, Saeki T, Sahani D, Sato Y, Smyrk T, Stone JR, Takahira M, Umehara H, Webster G, Yamamoto M, Yi E, Yoshino T, Zamboni G, Zen Y, Chari S. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum. 2012;64(10):3061-3067. doi:10.1002/art.34593.
  29. Vasil'ev V, Pal'shina S, Simonova M, Logvinenko O, Sedyshev S, Mitrikov B, Probatova N, Kokosadze N, Safonova T, Aleksandrova E, Nasonov E. The first experience of using rituximab in Mikulicz's disease. Terapevticheskii arkhiv. 2010;82(6):62-66. (In Russ.)
  30. Sedyshev S, Vasil'ev V, Kovrigina A, Logvinenko O, Rodionova E, Safonova T, Gaiduk I, Silin A, Komov D, Nasonov E. IgG4-related disease: patient group characterization and rituximab therapy. Terapevticheskii arkhiv. 2013;2:48-53. (In Russ.)
  31. Khosroshahi A, Carrthers MN, Deshpande V, Unizony S, Bloch DB, Stone JH. Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients. Medicine. 2012;91:57-66.  doi:10.1097/MD.0b013e3182431ef6.
  32. Amaud L, Harvier B, Neel A, Hamidou MA, Kahn JE, Wechsler B, Pérez-Pastor G, Blomberg B, Fuzibet JG, Dubourguet F, Marinho A, Magnette C, Noel V, Pavic M, Casper J, Beucher AB, Costedoat-Chalumeau N, Aaron L, Salvatierra J, Graux C, Cacoub P, Delcey V, Dechant C, Bindi P, Herbaut C, Graziani G, Amoura Z, Haroche J. CNS involvement and treatment with interferon-α are independent prognosis factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients. Blood. 2011;117(10):2778-2782. doi:10.1182/blood-2010-06-294108.
  33. Raina A, Yadav D, Krasinskas AM, McGrath KM, Khalid A, Sanders M, Whitcomb DC, Slivka A. Evaluation and management of autoimmune pancreatitis: experience at a large US center. Am J Gastroenterol. 2009;104:2295-2306. doi:10.1038/ajg.2009.325.
  34. Masaki Y, Dong L, Kurose N, Kitagawa K, Morikawa Y, Yamamoto M, Takahashi H, Shinomura Y, Imai K, Saeki T, Azumi A, Nakada S, Sugiyama E, Matsui S, Origuchi T, Nishiyama S, Nishimori I, Nojima T, Yamada K, Kawano M, Zen Y, Kaneko M, Miyazaki K, Tsubota K, Eguchi K, Tomoda K, Sawaki T, Kawanami T, Tanaka M, Fukushima T, Sugai S, Umehara H.. Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis. 2009;68:1310-1315. doi:10.1136/ard.2008.089169.
  35. Vasilyev V, Sokol E, Rodionova E, Pal'shina S, Aleksandrova E, Radenska-Lopovok S, Probatova N, Kokosadze N, Kovrigina A, Safonova T, Borovskaya A, Gaiduk I. IgG4-related salivary gland lesions. Terapevticheskii arkhiv. 2015;8:92-102. (In Russ.)
  36. Wallace ZS, Deshpande V, Stone JH. Ophthalmic manifestations of IgG4-related disease: Single-center experience and literature review. Seminars in Arthritis and Rheumatism. 2014;43:806-817.  doi:10.1016/j.semarthrit.2013.11.008.
  37. Kermani TA, Crowson CS, Achenbach SJ, Luthra HS. Idiopathic Retroperitoneal Fibrosis: A Retrospective Review of Clinical Presentation, Treatment, and Outcomes. Mayo Clinic Proceedings. 2011;86(14):297-303.  doi:10.4065/mcp.2010.0663.
  38. Yamamoto M, Tabeya T, Naishiro Y, Yajima H, Ishigami K, Shimizu Y, Obara M, Suzuki C, Yamashita K, Yamamoto H, Hayashi T, Sasaki S, Sugaya T, Ishida T, Takano K, Himi T, Suzuki Y, Nishimoto N, Honda S, Takahashi H, Imai K, Shinomura Y. Value of serum IgG4 in the diagnosis of IgG4-related disease and differentiation from rheumatic disease and other diseases. Modern Rheumatol. 2012;22:419-425.  doi:10.1007/s10165-011-0532-6.
  39. Strehl JD, Hartman A, Agaimy A. Numerous IgG4-positive plasma cells are ubiquitous in diverse localized non-specific chronic inflammatory conditions and need to be distinguished from IgG4-related systemic disorders. J Clin Pathol. 2011;64:237-243.  doi:10.1136/jcp.2010.085613.
  40. Alan A, McKelvie P. IgG4-Related Ophthalmic Disease. Part I: Background and Pathology. Ophthalmic Plastic and Reconstructive Surgery. 2015;31(2):83-88.  doi:10.1097/IOP.0000000000000363.
  41. Alan A, McKelvie P. IgG4-Related Ophthalmic Disease. Part II: Clinical Aspects. Ophthalmic Plastic and Reconstructive Surgery. 2015;20(20):1-12.  doi:10.1097/IOP.0000000000000364.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.